DeutschNewstral
Article
jdsupra.com on 2016-11-08 20:38
FDA Approves Expanded Use of Amgen’s Enbrel®
Related news
- PFDA approves biosimilar competitor to Amgen’s Enbrelpacbiztimes.com
FDA Approves Novartis’s Biosimilar to Amgen’s Enbrelwsj.com- PFDA approves biosimilar of Amgen’s Enbrelpacbiztimes.com
- PEuropeans OK expanded use of Amgen’s Blincytopacbiztimes.com
- PFDA approves Amgen’s Blincytopacbiztimes.com
- FDA Approves Amgen’s Cholesterol Drugwsj.com
- PFDA approves Amgen’s Kyprolispacbiztimes.com
FDA approves expanded use of remdesivir in moderate COVID-19 patientsThe Jerusalem Post (JPost.com)- FDA Approves Amgen’s AVSOLA (infliximab-axxq)jdsupra.com
- MFDA approves biosimilar to Amgen's Enbrelmarketwatch.com
- PFDA approves biosimilar of Amgen’s Neulastapacbiztimes.com
Coronavirus: FDA approves emergency use of remdesivirSan Jose Mercury News- PFDA approves Amgen’s Parsabiv drug to treat chronic kidney diseasepacbiztimes.com
- FDA Approves Amgen’s Biosimilar of Avastin®jdsupra.com
- FDA Approves Amgen’s Biosimilar Version of Humirawsj.com
FDA backs expanded use of medical abortion pillswtimes.com- COVID: FDA approves 1st emergency use of antibody drugSan Jose Mercury News
- PAmgen’s Humira biosimilar delayed, Enbrel approvedpacbiztimes.com
- FDA Approves Amgen’s RIABNI™ (Rituximab-arrx) for Adults With Moderate to Severe Rheumatoid Arthritisjdsupra.com
- PJudge blocks sale of competitor for Amgen’s Enbrelpacbiztimes.com